BioCorRx Announces IRB Approval to Begin Phase I Clinical Trial of BICX104, an Implantable Biodegradable Naltrexone Pellet for the Treatment of Opioid Use Disorder Mar 16, 2022
BioCorRx Announces Orange County Research Center as Clinical Trial Site for First-In-Human Clinical Trial of BICX104 Feb 14, 2022
BioCorRx Files Patent Application with the Russian Patent Office (Rospatent) for Naltrexone Implant Oct 7, 2021